PALOMA-3

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

December, 2024

PALOMA-3

Jun 23, 2024, 10:44 | Blog

IV vs Subcutaneous amivantamab in EGFR NSCLC

Eric K. Singhi shared a post by Stephen V Liu, on X: "Absolutely agree with this! Compared with…

Jun 21, 2024, 13:43 | Insight

Luca Dezzani: We are requesting approval from the U.S. FDA EGFR-mutated NSCLC therapy

Luca Dezzani, Vice President of US Oncology Medical Affairs at Johnson & Johnson, shared a…

Jun 13, 2024, 15:48 | Insight

Stephen Liu on a paper by Natasha Leighl, et al.

Stephen Liu recently shared a post on X: "PALOMA-3 results at Journal of Clinical Oncology…

Jun 8, 2024, 16:06 | Blog

Reflections on ASCO24 by Jill Feldman

Jill Feldman shared on X/Twitter: "1. What an honor to meet Dr. Lynn Schuchter. I'm grateful…

Jun 1, 2024, 11:24 | Blog

Narjust Florez: It is not only about living longer but also living well for our patients

Narjust Florez shared a post by Shankar Siva, Professor, Faculty of Medicine at University of Melbourne on…

All: 5 Posts: 1 - 100

'

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

'

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

'

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

'

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

'

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023